SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-219308
Filing Date
2019-08-13
Accepted
2019-08-12 21:35:56
Documents
1
Group Members
KEVIN FERROVATERA CAPITAL MANAGEMENT LLCVHPM HOLDINGS LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 TO SCHEDULE 13D d792530dsc13da.htm SC 13D/A 80098
  Complete submission text file 0001193125-19-219308.txt   81923
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86624 | Film No.: 191018089
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022
Business Address C/O VATERA HOLDINGS LLC 499 PARK AVENUE, 23RD FLOOR NEW YORK NY 10022 212 590 2950
Vatera Healthcare Partners LLC (Filed by) CIK: 0001722413 (see all company filings)

IRS No.: 271020233 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A